Monte Rosa Therapeutics nets $95m Series C

Monte Rosa Therapeutics, a developer of precision medicines, has secured $95 million in Series C financing.

Monte Rosa Therapeutics, a developer of precision medicines, has secured $95 million in Series C financing. Avoro Capital Advisors led the round.

Source: Press Release